Xebios Diagnostica Group introduces:

CHROMagar Candida Plus – for detection and differentiation of major clinical Candida species, including C. auris

Candida are yeast species involved in various infections called candidiasis, which can affect damaged skin, respiratory tract, digestive and urogenital systems. These candidiases can be severe with significant morbidity for nosocomial infections or in immunocompromised patients. Although C. albicans is still the main species involved, the use of antifungal agents has given rise to other species such as C. tropicalis, C. krusei and C. glabrata.

In 2016, the World Health Organization added C. auris to this list, with a prevalence of over 90 % resistant to fluconazole. In addition, some strains are multidrug resistant to amphotericin B, voriconazole, and/or echinocandins.

CHROMagar™️ Candida Plus is the first chromogenic isolation medium to detect and differentiate C. auris in addition to other major clinical Candida species such as C. albicans, C. tropicalis, C. glabrata or C. krusei.

Medium Performance

• HIGH SPECIFICITY • Differentiation of the most common Candida species with very high specificity (C. albicans, C. tropicalis, C. krusei with 100% specificity)
• UNIQUE DIFFERENTIATION • The medium differentiats C. auris from other Candida species.
• PERFORMANCE CHARACTERISTICS FOR C. AURIS: Specificity 100 %, Sensitivity 100 %

Due to the medium’s high specificity, it can also be used as a screening tool in case of outbreaks for patient samples and surfaces suspected of being contaminated with C. auris.

Are you interested in our product: please contact our sales team (sales@xebios.com) at any time.

CHROMagar Microbiology

XDG • Excellent Environment & Life